Trials / Completed
CompletedNCT03060941
Promoting Activity in Cancer Survivors
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 355 (actual)
- Sponsor
- University of Texas Southwestern Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A randomized multi-component physical activity intervention for breast cancer survivors.
Detailed description
The research project is a study to assess the effects of a multi-component intervention in increasing physical activity among breast cancer survivors. Individuals meeting inclusion/exclusion criteria will be randomized to one of sixteen intervention groups for the 6 months. Intervention components will include print-based education, self-monitoring, Active Living counseling, supervised exercise sessions, and facility access. Blood samples will be collected at baseline. Assessments (anxiety, stress, sleep) and sample collection will also occur at 3 time points during the intervention (Weeks 13 and 25). Changes in physical activity will be assessed for each intervention group.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Physical activity education | Participants will be given educational materials on how to increase physical activity levels. |
| BEHAVIORAL | Facility access | Participants will receive at 6 month membership to a local fitness facility. |
| BEHAVIORAL | Supervised exercise sessions | Participants will attend weekly supervised exercise sessions with an exercise interventionist. |
| BEHAVIORAL | Self-monitoring (Fitbit) | Participants will be given a Fitbit to monitor their physical activity levels. |
| BEHAVIORAL | Active living counseling | Participants will attend 12 biweekly educational sessions about how to increase their physical activity levels. |
Timeline
- Start date
- 2017-12-04
- Primary completion
- 2020-02-28
- Completion
- 2020-02-28
- First posted
- 2017-02-23
- Last updated
- 2021-01-26
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03060941. Inclusion in this directory is not an endorsement.